Minimal Requirement for a Lentivirus Vector Based on Human Immunodeficiency Virus Type 1

The use of human immunodeficiency virus vectors for gene therapy is hampered by concern over their safety. This concern might be ameliorated, in part, if the viral accessory genes and proteins could be eliminated from the vector genomes and particles. Here we describe a minimal vector system that is...

Popoln opis

Bibliografske podrobnosti

izdano v:	J Virol
Principais autores:	Kim, V. Narry, Mitrophanous, Kyriacos, Kingsman, Susan M., Kingsman, Alan J.
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1998
Teme:	Gene Therapy
Online dostop:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC109441/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9420292/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.72.1.811-816.1998
Oznake:	Označite Brez oznak, prvi označite!